LGT Capital Partners Q2 Portfolio Shifts: New Positions in Healthcare & Tech

LGT Capital Partners Ltd.'s portfolio saw significant changes during Q2 2026. The investment firm increased positions notably in Boston Scientific (BSX) and Netflix (NFLX), while reducing holdings of Microsoft (MSFT) and Alphabet (GOOGL).

By Insiderset.Aug 8, 2026, 6:33 AM
LGT Capital Partners Q2 Portfolio Shifts: New Positions in Healthcare & Tech

As of June 30, 2026, LGT Capital Partners Ltd., a prominent investment manager, has released its portfolio activity report for the second quarter. This filing provides valuable insights into stock purchases and sales made by this institutional investor during Q2.

The firm's overall portfolio maintained a substantial value of approximately $1.97 billion as of June 30th. Technology remains a dominant sector, accounting for nearly 40% ($775 million) of the total holdings, followed closely by Healthcare (around 16%) and Financial Services.

Several notable new positions emerged during this quarter:

  • Boston Scientific Corporation, symbol BSX, experienced a massive increase with a 100% buy. This suggests strong confidence in the company's prospects.
  • Netflix Inc., symbol NFLX, saw its stake grow by approximately +52%, indicating renewed interest or a significant purchase.
  • DEXCOM, symbol DXCM (+37.84%) and Agilent Technologies Inc. (A) (-13.17%, but still held), show activity across different sectors, with some experiencing significant changes while others maintained their positions despite market shifts.

Conversely, the report highlights substantial reductions in existing holdings:

  • Palantir Technologies Inc., symbol PANW, suffered a significant sell with an approximate -60.51% reduction from Q1 levels.
  • Microsoft Corporation (MSFT) experienced a notable decrease of about 31.05%, suggesting a major divestment or reduced confidence in the stock's future performance.
  • Alphabet Inc. (GOOGL) also saw its stake shrink by roughly -20.22% during this period, indicating a significant reduction.

The portfolio's sector allocation reflects these changes and the overall investment strategy:

  • Technology remains heavily weighted at nearly 40% of the total value ($775 million).
  • Healthcare allocation increased slightly to around $316 million (16%) due to new positions like Boston Scientific.
  • The firm also maintains significant exposure in Financial Services and Consumer Defensive sectors, though specific changes within these categories weren't highlighted as large-scale buys or sells by LGT Capital Partners Ltd. based on the provided data.

Overall, this quarter's filing indicates a dynamic approach to portfolio management for LGT Capital Partners Ltd., involving both substantial new investments and significant reductions in certain positions. Investors can explore these specific activities further through detailed analysis available at LGT Capital Partners Ltd.'s institutional profile on Insiderset.